[1] Wegermann K, Henao R, Diehl AM, et al. Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: a pilot study. PLoS One, 2018,13:e0204308.
[2] El-Deeb TS, Bakkar SM, Eltoony L, et al. The adipokine chemerin and fetuin-a serum levels in type 2 diabetes mellitus: relation to obesity and inflammatory markers. Egypt J Immunol, 2018,25:191-202.
[3] Tada T, Kumada T, Toyoda H, et al. New scoring system combining the FIB-4 index and cytokeratin-18 fragments for predicting steatohepatitis and liver fibrosis in patients with nonalcoholic fatty liver disease. Biomarkers, 2018,23:328-334.
[4] 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南(2010年修订版). 中华内科杂志, 2010, 49:275-278.
[5] Zhang Z, Wang J, Wang H. Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus. Exp Ther Med, 2018,15:2936-2940.
[6] Kobayashi N, Kumada T, Toyoda H, et al. Ability of cytokeratin-18 fragments and FIB-4 index to diagnose overall and mild fibrosis nonalcoholic steatohepatitis in Japanese nonalcoholic fatty liver disease patientsp. Dig Dis, 2017,35:521-530. |
